Atlas Trials

A Study to Assess the Efficacy and Safety of CD-008-0045 in Patients With Generalized Anxiety Disorder

Clinical trial NCT04598867 · UNKNOWN

Trial details

NCT number
NCT04598867
Sponsor
ChemRar Research and Development Institute, LLC
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Anxiety Disorder Generalized
Start date
2020-12-01
Primary completion
2023-05-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.